T. Ming Chu

2.6k total citations
53 papers, 2.1k citations indexed

About

T. Ming Chu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, T. Ming Chu has authored 53 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Oncology. Recurrent topics in T. Ming Chu's work include Glycosylation and Glycoproteins Research (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Prostate Cancer Treatment and Research (8 papers). T. Ming Chu is often cited by papers focused on Glycosylation and Glycoproteins Research (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Prostate Cancer Treatment and Research (8 papers). T. Ming Chu collaborates with scholars based in United States, Netherlands and Switzerland. T. Ming Chu's co-authors include Gerald P. Murphy, Lawrence D. Papsidero, E. Douglas Holyoke, Mehrdad Nadji, Azorides R. Morales, Seyed Ziaeddin Tabei, Albert Castro, Gustavo Reynoso, Miguel A. Rubio and Ming C. Wang and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

T. Ming Chu

52 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Ming Chu United States 24 849 625 556 402 337 53 2.1k
George H. Barrows United States 20 613 0.7× 630 1.0× 399 0.7× 147 0.4× 296 0.9× 40 1.9k
Michael Kraut United States 24 1.0k 1.2× 832 1.3× 489 0.9× 169 0.4× 254 0.8× 58 1.9k
E. Douglas Holyoke United States 24 415 0.5× 969 1.6× 351 0.6× 288 0.7× 323 1.0× 69 1.6k
W. J. Mooi Netherlands 26 840 1.0× 1.2k 1.9× 1.1k 1.9× 195 0.5× 432 1.3× 60 2.7k
Raymond Tubbs United States 28 375 0.4× 936 1.5× 815 1.5× 283 0.7× 302 0.9× 72 2.5k
Kenkichi Koiso Japan 22 483 0.6× 421 0.7× 451 0.8× 107 0.3× 743 2.2× 129 1.8k
Fulvio Lonardo United States 32 1.4k 1.7× 1.4k 2.3× 1.3k 2.4× 346 0.9× 341 1.0× 79 3.4k
Hiroyuki Yamaguchi Japan 26 685 0.8× 927 1.5× 599 1.1× 130 0.3× 518 1.5× 156 2.0k
James L. Bennington United States 25 637 0.8× 595 1.0× 910 1.6× 88 0.2× 363 1.1× 49 2.2k
Kuniyuki Oka Japan 24 405 0.5× 629 1.0× 413 0.7× 144 0.4× 348 1.0× 101 1.8k

Countries citing papers authored by T. Ming Chu

Since Specialization
Citations

This map shows the geographic impact of T. Ming Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Ming Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Ming Chu more than expected).

Fields of papers citing papers by T. Ming Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Ming Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Ming Chu. The network helps show where T. Ming Chu may publish in the future.

Co-authorship network of co-authors of T. Ming Chu

This figure shows the co-authorship network connecting the top 25 collaborators of T. Ming Chu. A scholar is included among the top collaborators of T. Ming Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Ming Chu. T. Ming Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chu, T. Ming, et al.. (1996). Localization of seminal plasma transforming growth factor-β1 on human spermatozoa: an immunocytochemical study. Fertility and Sterility. 66(2). 327–330. 39 indexed citations
3.
Chu, T. Ming, et al.. (1993). Transforming Growth Factor β as an Immunosuppressive Protein in Human Seminal Plasma. American Journal of Reproductive Immunology. 30(1). 1–8. 59 indexed citations
4.
Lin, Tsung H. & T. Ming Chu. (1993). Enhancement of Perforin by Retinoic Acid Is Mediated by Protein Kinase C. Biochemical and Biophysical Research Communications. 191(3). 937–942. 4 indexed citations
5.
Lee, Hansoo, T. Ming Chu, & Ching‐Li Lee. (1991). Endogenous protein substrates for prostatic acid phosphatase in human prostate. The Prostate. 19(3). 251–263. 7 indexed citations
6.
Chu, T. Ming, et al.. (1991). Synergistic antitumor activity of interleukin-2 and cimetidine against syngeneic murine tumor. Cancer Immunology Immunotherapy. 33(1). 9–14. 11 indexed citations
7.
Chu, T. Ming, et al.. (1990). Enhancement of murine lymphokine-activated killer cell activity by retinoic acid.. PubMed. 50(10). 3013–8. 11 indexed citations
8.
Chao, Tsu-Yi & T. Ming Chu. (1989). Effect of indomethacin on tumor-infiltrating lymphocytes of a spontaneously developed murine mammary adenocarcinoma. Cancer Immunology Immunotherapy. 30(3). 158–164. 11 indexed citations
9.
Ohnishi, Hiroshi, et al.. (1989). Augmentation of murine lymphokine (rIL-2)-activated killer cell activity by indomethacin.. PubMed. 1(6). 318–22. 2 indexed citations
10.
Chu, T. Ming. (1987). Biochemical Markers for Human Cancer. Current topics in pathology. 77. 19–45. 13 indexed citations
11.
Loor, R., M Kuriyama, Hideo Inaji, et al.. (1984). Simultaneous evaluation of a pancreas-specific antigen and a pancreatic cancer-associated antigen in pancreatic carcinoma.. PubMed. 44(8). 3604–7. 9 indexed citations
12.
Chu, T. Ming, et al.. (1983). Purification and characterization of ribonucleases from human seminal plasma. Biochemical Journal. 215(3). 605–612. 4 indexed citations
13.
Papsidero, Lawrence D., Gary A. Croghan, Manabu Kuriyama, et al.. (1983). Monoclonal Antibody (F5) to Human Prostate Antigen. Hybridoma. 2(2). 139–147. 41 indexed citations
14.
Loor, Rueyming, et al.. (1982). Use of Pancreas-Specific Antigen in Immunodiagnosis of Pancreatic Cancer. Clinics in Laboratory Medicine. 2(3). 567–578. 10 indexed citations
15.
Papsidero, Lawrence D., et al.. (1979). Immune complexes in breast cancer patients as detected by Clq binding. Cancer. 44(5). 1636–1640. 25 indexed citations
16.
Ahmed, A. Razzaque & T. Ming Chu. (1976). CARCINOEMBRYONIC ANTIGEN IN DERMATOSES. The Lancet. 308(7980). 309–310. 3 indexed citations
17.
Harvey, Shashikumar R. & T. Ming Chu. (1975). Demonstration of two molecular variants of carcinoembryonic antigen by concanavalin A sepharose affinity chromatography.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(11 Pt 1). 3001–8. 23 indexed citations
18.
Chu, T. Ming, et al.. (1975). Pharmacoclinical study of oral estramustine phosphate (estracyt) in advanced carcinoma of the prostate. Urology. 5(2). 292–293. 23 indexed citations
19.
Merrin, Claude, G.P. Murphy, T. Ming Chu, & A Mittelman. (1974). Carcinoma of prostate. Urology. 3(2). 223–225. 5 indexed citations
20.
Bishop, Charles W., T. Ming Chu, & Zak K. Shihabi. (1971). Single Stable Reagent for Creatine Kinase Assay. Clinical Chemistry. 17(6). 548–550. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026